Investigation of the Role of Helicobacter Pylori ın the Etiopathogenesis of Current Aphthous Stomatitis

Similar documents
Helicobacter and gastritis

Ammara ismail, Fatima Javed, Memoona Ismail

Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans

Helicobacter pylori:an Emerging Pathogen

Objective: Helicobacter pylori infection is one of the most common bacterial infections in

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009

PREVALENCE AND CHARACTERIZATION OF HELICOBACTER PYLORI (H. PYLORI) INFECTION AND COLONIZATION IN DENTISTS

KEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia.

Research Article Concomitant Colonization of Helicobacter pylori in Dental Plaque and Gastric Biopsy

Helicobacter Connections. Barry Marshall

Magaji et al., Afr. J. Infect. Dis. 2(2): THE ROLE OF AN AGGRESSIVE FACTOR IN PEPTIC ULCER DISEASE (PUD)

Index. Note: Page numbers of article titles are in boldface type.

Framing Helicobacter pylori: The Etiology of Peptic Ulcers and Gastritis

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.

January 07, ANIMALS Digestive System Stomach.notebook. The Stomach. (cardiac sphincter) bbbbbbbbbbbbbbbbbb

Identification of Helicobacter Pylori in Dental Plaques

Keywords: coronary heart disease, oral hygiene, oral inflammatory diseases.

THE PREVALENCE OF HELICBACTER PYLORI AMONG PATIENTS COMPLAINING FROM ABDOMINAL PAIN

RISK FACTORS OF BURNING MOUTH SYNDROME: UN UPDATE

Bacterial Mechanisms of Pathogenicity

/ : Ternopil State Medical University named after I. Gorbachevskogo Voli sqare, 1, Ternopil, 46001, Ukraine

Aphthous Ulcer Causes and Management. Prepared by : Yasmeen Al Sultan Heba Atalla. Supervised by : Dr. Nael AL massri

The Nobel Prize in Physiology or Medicine for 2005

5. Which component of the duodenal contents entering the stomach causes the most severe changes to gastric mucosa:

Pathogenesis of Infectious Diseases. CLS 212: Medical Microbiology

H.Pylori IgG

H.Pylori IgG Cat # 1503Z

H.Pylori IgM Cat # 1504Z

2 االستاذ المساعد الدكتور خالد ياسين الزاملي \ مناعة \ المرحلة الثانية \ التحليالت المرضية \

The Aging Digestive System

Urea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013

H. pylori Antigen ELISA Kit

Faculty of Veterinary Medicine Universiti Malaysia Kelantan. Immunology and Serology (DVT2153)

H. pylori IgM. Cat # H. pylori IgM ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate

Dr Hamed Al-Zoubi Ass. Prof. / Medical Microbiology

HELICOBACTER PYLORI UPDATE

Case presentations: The pitfalls in diagnosis and management of oral lesions in cancer patients

Infection and Disease I. Humans as Habitats

Peptic Ulcer (Seminar) READ ONLINE

H. pylori IgM CLIA kit

The significance of Helicobacter pylori in the approach of dyspepsia in primary care Arents, Nicolaas Lodevikus Augustinus

Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori

Microbiology - Problem Drill 21: Microbial Diseases of the Digestive System

Oral Pathology Syllabus for English-Speaking Students

Saliva. Introduction. Salivary Flow. Saliva and the Plaque Biofilm. The Minerals in Saliva

Corporate Medical Policy

Pathogenicity of Infectious Diseases

Lavanya Nutankalva,MD Consultant: Infectious Diseases

Clinical Mucosal Immunology

Dr Hamed Al-Zoubi Ass. Prof. / Medical Microbiology

Helicobacter pylori 幽門螺旋桿菌 馬偕紀念醫院新竹分院一般內科, 肝膽腸胃科陳重助醫師

A PLACEBO CONTROLLED TRIAL OF BISMUTH SALICYLATE IN HELICOBACTER PYLORI ASSOCIATED GASTRITIS

Types of infections & Mode of transmission of diseases

See external label 2 C-8 C Σ=96 tests Cat # 1505Z. MICROWELL ELISA H.Pylori IgA Cat # 1505Z

H.pylori IgA Cat #

THE ASSOCIATION OF ETIOLOGICAL FACTORS IN CHRONIC GASTRITIS

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.

PATHOGENESIS AND CURRENT TREATMENT OF H. PYLORI INFECTION. Jiannis Vlachogiannakos

Digestive System. Digestion Myths

Biomarkers into saliva

Oral problems. Mouth Ulcer and Cold sore. Lec-2

Pathogens of the Digestive System

Biology of the Salivary Glands 513 (KEY) FINAL Examination June 26, 1997 To see correct answers, show hidden text (C) (B)

Elkins School District

Gilles Jequier. Commercial Director Organobalance, a Novozymes Company

School Nursing and Health. Standard Precautions. (aka Universal Precautions)

INFLUENCE OF SILICAGEL CONTAINING GOLD AND SILVER NANOPARTICLES ON THE BIOCHEMICAL INDICES OF EXPERIMENTALLY-INDUCED INFLAMMATION OF ORAL MUCOSA

Lymphocytic Gastritis, Isolated Type Occurring in Family Members. A Case Report.

Peptic Ulcer (Seminar) READ ONLINE

Chapter 21 NUTRITION AND DIGESTION

2014 Pearson Education, Inc. CHAPTER 14 Infection, Infectious Diseases, and Epidemiology

EVALUATION ACTIVITIES OF CHITOSAN ASCORBATE AGAINST RODS OF HELICOBACTER PYLORI ISOLATED FROM GINGIVAL POCKETS AND ATHEROSCLEROTIC PLAQUES

M I C R O B I O L O G Y WITH DISEASES BY TAXONOMY, THIRD EDITION

Gastric And Duodenal Ulcer

SCREENING OF GASTRO-INTESTINAL TRACT S MALIGNANT NEOPLASMS

California Association for Medical Laboratory Technology

Diet and Gastrointestinal Problems

CSLO8. Explain transmission and virulence mechanisms of cellular and acellular infectious agents.

National Digestive Diseases Information Clearinghouse

Fecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar

Association of Helicobacter pylori infection with Atrophic gastritis in patients with Dyspepsia

LESIONS OF THE ORAL CAVITY ORAL CAVITY. Oral Cavity Subsites 4/10/2013 LIPS TEETH GINGIVA ORAL MUCOUS MEMBRANES PALATE TONGUE ORAL LYMPHOID TISSUES

Unit 1: Asepsis and Infection Control

Prevalence of Helicobacter pylori in Patients with End Stage Renal Disease

Incidence and profile of Helicobacter pylori infection among HIV positive patients

ORAL MANIFESTATIONS IN LIVER DISEASES

Association Between Helicobacter pylori Infection and Risk of Periodontal Diseases in Han Chinese: A Case-Control Study

THE AMERICAN ACADEMY OF PERIODONTOLOGY

GASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali

Immunohistochemical Confirmation of Infections

VIRUS. Viral infection causing, or associated with diseases of the oral mucosa : Herpes Simpleks 1 & 2

Sequioa Education Systems, Inc. 1

Foundations in Microbiology

The Oral Cavity. Image source:

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Relationship between Herpes Simplex Virus Type- 1 and periodontitis

MOSAIC APPEARANCE OF GASTRIC MUCOSA AS A PREDICTOR FOR HELICOBACTER PYLORI INFECTION

INTRODUCING YOUR GUT BACTERIA

594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications

A Rare case of Tubercular Gingivitis Case Report

Transcription:

Investigation of the Role of Helicobacter Pylori ın the Etiopathogenesis of Current Aphthous Stomatitis Nino Tsilosani, Professor Nino Khimshiashvili, Professor Sophio Salia, MA Grigol Robakidze University, Tbilisi, Georgia Abstract Nowadays, etiopathogenesis of recurrent aphthous stomatitis is not fully understood. Chronic gastritis, gastric and duodenal ulcers, diseases associated with H. Pylori, often attend this oral pathology. It is acknowledged, that H. Pylori is a conditional-pathogenic microbe which is included in normal mucosalflora of the gastrointestinal tract and oral cavity. Oral cavity appears to be a secondary reservoir for the microorganisms and also a source of gastric reinfection after the eradicative treatment in case of gastroduodenal pathologies. H. Pylori has got ability to enhance aggressive factors and considerably reduce mucous membrane protective factors. In order to carry out further investigations on this issue, we have initiated observation on the patients with recurrent aphthous stomatitis. The aim of the study was to determine whether there is a correlation between Helicobacter Pylori infection and recurrent aphthous stomatitis. The results of the given investigation show there is a higher possibility that the role of Helicobacter Pylori in the etiopathogenesis of recurrent oral ulcers (aphthae) is significant. Keywords: Recurrent aphthous stomatitis, H. Pylori, chronic gastritis, gastric and duodenal ulcers Introduction Recurrent aphthous stomatitis (K-12.0), recurrent oral ulcers (aphthae), is common both in children and adults, primarily in women. Although its Etiopathogenesis is not fully understood, there still exist several theories: - Genetic predisposition - Genetic predisposition was first ascertained in 60ies in Jordan where a survey was conducted (6). According to the survey among the patients 66.4% cases with family history of aphthous stomatitis was revealed. 455

- Allergic disposition, nature - Immunological aspects of the disease encourage us to assume its allergic genesis. Bacteria, viruses, food, and medications can cause cellular and humoral immunity response, accompanied by the damage of oral mucosal epithelium (12). - The role of bacteria and viruses - According to the existing literature, some scientists do not exclude that bacteria and viruses, such as Streptococus, Citomegalovirus, Varicella Zoster, Herpes Simplex may play etiological role (13, 14). - Vitamin and mineral deficiency - According to Barnadas findings, in 26,2% of patients iron deficiency, folic acid deficiency and vitamin B-12 deficiency has been revealed (2). - Stress - Greek and Indian scientists say that in the pathogenesis of the recurrent aphthous stomatitis an important role plays cortisol levels in blood and saliva (7). - Gastrointestinal diseases - In recent decades, investigations on the role of H. Pylori in the etiopathogenesis of recurrent aphthous stomatitis has been appearing. (8, 10) Chronic gastritis, gastric and duodenal ulcers, diseases associated with H. Pylori, often attend this oral pathology. Helicobacter Pylori appears to be one of the most prevalent infections in the world. The highest levels of the infection are observed in developing countries. But the level of the infection is quite high even in developed countries. According to Marshall s data 20% of the population above 40 and 50% of the population above 60 are infected with H. Pylori in developed countries. Infection levels are higher in children, rather than in adults, both in developing and developed countries. Diseases associated with H. Pylori are as follows: chronic gastritis, gastric and duodenal ulcers. The fact, that gastrointestinal tract disorders affect the mouth, can be explained by the morphofunctional similarity of the oral cavity and gastrointestinal tract mucosa (3). Besides, as we know, oral cavity mucosa has got a broad field of receptors, which may be reflectively affected by any internal organ dysfunctions (11). Ways of H. Pylori infection transmission: fecal-oral route, oral-oral route and iatrogenic transmission (5). The gate for the infection is the mouth. It should be noted that there exist occupational risk factors among various professionals, but H. Pylori is most prevalent in dentists. Most likely it is transmitted via bacterial aerosol cloud, which is formed in the process of dental procedures. H. Pylori has got ability to enhance aggressive factors and considerably reduce mucous membrane protective factors. About 2/3 of H. Pylori strains manufacture, the so called vacuolating cytotoxins, which cause the death of a cell. The manufactured active 456

enzymes, such as ureases, phospholipases, catalases, oxidases, hemolysins, proteases and so on not only destroy the wholeness, integrity of epithelial cells, but they also reduce protective functions of the mucous membrane. In addition, vascular endothelium is damaged and tissue trophism is destroyed (15). Nowadays, it is acknowledged that H. Pylori may be a conditionalpathogenic microbe which is included in normal mucosal flora of the gastrointestinal tract and oral cavity (4). Oral cavity appears to be a secondary reservoir for the microorganisms and also a source of gastric reinfection after the eradicative treatment in case of gastroduodenal pathologies. H. Pylori may be found in saliva, gingival fluid, soft plaque, periodontal pocket contents, tongue and cheek mucosa and prosthetic constructions (dentures) (9). Oral colonization mechanism of these microorganisms has not been studied adequately yet and there is no data about the correlation between microbe persistence and dental status in the oral cavity, and the role of H. Pylori in the etiopathogenesis of recurrent aphthous stomatitis has not been proven as well. In recent decades, investigations on the role of H. Pylori in the etiopathogenesis of recurrent aphthous stomatitis has been appearing. According to the data of the survey conducted in 2015, H. Pylori infection was detected in 65% of patients with gastrointestinal pathologies, and they had recurrent aphthous stomatitis simultaneously (1). After efficient eradication therapy the number of the aphthae had been reduced considerably and vitamin B 12 level had been increased in the blood. In order to carry out further investigations on this issue, we have initiated observation on the patients with recurrent aphthous stomatitis complaints at Gr. Robakidze University Dental Clinic Alma Dental Studio since February, 2016. The aim of the study was to determine whether there is a correlation between Helicobacter Pylori infection and recurrent aphthous stomatitis. Materials and Methods 19 patients aged 6-39 (6 children, 9 females and 4 males) were included in the study. None of the patients had had a diagnosis of gastroduodenal pathology before. All of the patients were investigated for Helicobacter Pylori infection. To ensure the presence of bacteria, a noninvasive rapid urease test (RUT) was used in all the nineteen patients. The test results appeared to be positive in all the nineteen cases. The patients were referred to the gastroenterologist to get a consultation and further examination. From 19 only 16 patients visited gastroenterologist. 457

The results and review of the research According to endoscopic findings, only 5 of the patients appeared not to have any kind of gastroduodenal disorders, 3 of them were diagnosed with duodenal ulcer, 8 of them had chronic form of erosive gastroduodenitis. All the 16 patients underwent a helicobacter eradication therapy. Simultaneously the patients were treated with local symptomatic treatment of recurrent aphthous stomatitis (treating mucous membrane with antiseptics, applying proteolytic enzymes to aphthae, administering medications stimulating epithelization, administering antihistamine medications Per os and local immunity stimulators). On the 5-th/7-th day of the treatment all the patients had marked improvement of the oral cavity mucous membrane and reduction of the aphtae in size, epithelization signs were also present. After 4 weeks of treatment no complaints or clinical manifestations have occurred in these patients. All the patients have been under outpatient observation. Since then until August, 2016 no aphthous stomatitis recurrence had been detected except for one case (a male aged 32 with duodenal ulcer). The results of the given study show there is a higher possibility that the role of Helicobacter Pylori in the etiopathogenesis of recurrent aphthous stomatitis is significant. Therefore, in order to study the issue more deeply, further complex investigation of the issue is being planned at the University Clinic. As the ascertainment of the role of Helicobacter Pylori in the etiopathogenesis of recurrent aphthous stomatitis is of great importance, not only in the sense of this certain oral pathology treatment, but also in the sense of preventing formation of ulcers in the gastrointestinal tract, the study will include different methods in diagnosing Helicobacter Pylori infection: Urease Rapid Test, serologic studies (to reveal antibodies), and investigation of the tissue sample (bioptate) taken from the damaged area of the oral mucous membrane. References: Rabinovich O. F. Aspects of etiology and pathogenesis of recurrent aphthous stomatitis. Clinical Dentisry, 2015. 4. 9. Ragan B., Ahmed J., Shenoy N., Denny C., Ongole R., Binnal A. Assessment of quality of life in patients with chronic oral mucosal diseases; a questionnaire-based study-perm J. -2014;18(1);123. Borovskiy E. V. et al. Therapeutic stomatology. Diseases of a mucous membrane of an oral cavity. Part 3. [Online resource]: text-book / Ed. G. M. Barera. II edition. Moscow: Medicine, 2015. 256 p. Diagnosis and epidemiology of Helicobacter pylori infection / X. Calvet, M. J. 458

Mimuro H. Strategy of Helicobacter pylori to enhance colonization of the stomach / H. Mimuro // Nippon SaikingakuZasshi. 2009. Vol. 64 (2). P. 311-317. Safadi R. A. Prevalence of recurrent aphthous ulceration in Jordanian dental patients.-bmc Oral Health. 2009, 9, 31-36. Albanidou-Farmaki E., Markopoulos A.K., Epivatianos A., Farmakis K. et al. Increased anxiety level and high salivary and serum cortisol concentrations in patients with recurrent aphthouse stomatitis. Tohoku J Exp Med. 2008; 214(4); 291-6. Mansour-Ghanaei F, Asmar MM, Bagherzadeh A.H. Helicobacter Pylori infection in oral lesions of patients with recurrent apthtouse stomatitis. Med Sci Monit-2005, 11(12), 576-9. Arutyunov S. D. Features of condition of tissues of a parodont at patients with peptic ulcer of the duodenum associated with Helicobacter pylori / S. D. Arutyunov, I. V. Mayev, N. V. Romanenko//Parodontology. No. 3, 2005. Pp. 30-33. Fitscer A. M. Cherubini K., Chies J., Dias S. A. Association between h.pylori and recurrent aphthouse stomatitis in children and adolescents, J Oral Path Med, 2004, 33, (3), 129-32. Lukinykh L.M. et al. Diseases of oral cavity. Nizhny Novgorod: Nizhny Novgorod State Medical Academy, 2004. 510 с. Riggo M. P., Lennon A., Wraw D. Detection of Helicobacter Pylori DNA in Recurrent aphthous stomatitis tissue By PCR-J OralPathol Med. 2000, 29 (10);507-13. Ghodratnama F., Wray D., Bagg J. Detection of serum antibodies against cytomegalovirus, varicella zoster virus and human herpes virus 6 in patients with recurent aphthouse stomatitis, J Oral PatholMed-1999; 28, 1;12-5. Gorska R. An epidemiological study of oral recurent aphthouse stomatitis in children, adolescents and adults, ages from 13-24, PrzegEpid, 1997, 51 (3), 339-47. Marshall B.J. // Lancet. 1983. N 2. P. 1273 1275. 459